Сравнение различных режимов радиомодификации препаратом цисплатин при проведении лучевой терапии больным со злокачественными опухолями слизистой оболочки ротовой полости и ротоглотки

Oleg A. Gladkov, А В Важенин, Т. М. Шарабура et al. · Siberian Journal of Oncology · 2008

Chelyabinsk Regional Cancer Center Russian Scientific Center ofRoentgenoradiology, Chelyabinsk The randomized study was undertaken to compare 3 regimens of cisplatin administration in patients with oral cavity and oropharynx cancers. Patients of group A received cisplatin at a dose of 6 mg/m2 daily, group B40 mg/m2 daily and group C-100 mg/m2 every 3 weeks. Beginning from the first day of cisplatin administration all patients received 68-70 Gy radiotherapy (EBRT) with conventional fractionation 2 Gy per fraction, 5 days a week. For the total radiotherapy dose of 70 Gy, the least commulative dose of cisplatin was 210 mg/m2 in group A, 280 mg/m2 in group В and 300 mg/m2 in group C. The treatment was interrupted due to toxic reactions in 18 (81.8%) patients of group A, in 17 (65.4%) patients of group В and in 5 (41.7%) patients of group C. Despite the least commulative dose of cisplatin in group A, the rate of complete tumor resorption was higher in group A (27.3%) than in groups В and С (19.2% and 16.7%, respectively).

Cited by 0 works.

Authors